Deferasirox
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72205-389 -
Package NDC
72205-389-01 -
Package NDC
72205-389-02 -
Package NDC
72205-389-03 -
Package NDC
72205-389-05 -
Application number
ANDA209878 -
SPL ID
a03c7657-fdca-4acb-ad82-c24680e90eae -
SPL set ID
a03c7657-fdca-4acb-ad82-c24680e90eae -
UNII
V8G4MOF2V9 -
RxCUI
597768 -
RxCUI
597770 -
RxCUI
597772
What the source publishes
- Labeler
- Novadoz Pharmaceuticals LLC
- Active ingredients
- Deferasirox
- Form
- TABLET, FOR SUSPENSION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Deferasirox",
"splId": "a03c7657-fdca-4acb-ad82-c24680e90eae",
"labels": [
{
"setId": "a03c7657-fdca-4acb-ad82-c24680e90eae",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a03c7657-fdca-4acb-ad82-c24680e90eae",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a03c7657-fdca-4acb-ad82-c24680e90eae"
}
],
"routes": [
"ORAL"
],
"labeler": "Novadoz Pharmaceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-389-01)",
"package_ndc": "72205-389-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260129"
},
{
"sample": false,
"description": "90 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-389-02)",
"package_ndc": "72205-389-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20260129"
},
{
"sample": false,
"description": "1000 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-389-03)",
"package_ndc": "72205-389-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20260129"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (72205-389-05) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK",
"package_ndc": "72205-389-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20260129"
}
],
"productId": "72205-389_a03c7657-fdca-4acb-ad82-c24680e90eae",
"useDomain": "unknown",
"dosageForm": "TABLET, FOR SUSPENSION",
"productNdc": "72205-389",
"deaSchedule": null,
"genericName": "Deferasirox",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DEFERASIROX",
"strength": "125 mg/1"
}
],
"applicationNumber": "ANDA209878",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20191120",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000144",
"N0000175522",
"N0000185506",
"N0000187062",
"N0000182138"
],
"upc": [
"0372205389014",
"0372205391017",
"0372205390010"
],
"unii": [
"V8G4MOF2V9"
],
"rxcui": [
"597768",
"597770",
"597772"
],
"spl_set_id": [
"a03c7657-fdca-4acb-ad82-c24680e90eae"
],
"pharm_class_epc": [
"Iron Chelator [EPC]"
],
"pharm_class_moa": [
"Iron Chelating Activity [MoA]",
"Cytochrome P450 3A4 Inducers [MoA]",
"Cytochrome P450 2C8 Inhibitors [MoA]",
"Cytochrome P450 1A2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Novadoz Pharmaceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72205-389_a03c7657-fdca-4acb-ad82-c24680e90eae"